Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate

The exponential rise in molecular and genomic data has generated a vast array of therapeutic targets. Oligonucleotide-based technologies to down regulate these molecular targets have promising therapeutic efficacy. However, there is relatively limited success in translating this into effective in vi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Med
Autors principals: Satake, Noriko, Duong, Connie, Yoshida, Sakiko, Oestergaard, Michael, Chen, Cathy, Peralta, Rachael, Guo, Shuling, Seth, Punit P, Li, Yueju, Beckett, Laurel, Chung, Jong, Nolta, Jan, Nitin, Nitin, Tuscano, Joseph M
Format: Artigo
Idioma:Inglês
Publicat: Feinstein Institute for Medical Research 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5082301/
https://ncbi.nlm.nih.gov/pubmed/27455414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2015.00210
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars